Valuation: Viatris Inc.

Market Cap 19.75B 17.28B 15.93B 14.76B 28.03B 1,875B 28.48B 191B 74.28B 925B 74.15B 72.54B 3,198B P/E 2026 *
62.1x
P/E 2027 * 26.9x
Enterprise Value 31.94B 27.95B 25.76B 23.87B 45.32B 3,031B 46.05B 309B 120B 1,496B 120B 117B 5,171B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 2.05x
Free-Float
92.23%
Yield 2026 *
3%
Yield 2027 * 3.08%
1 day+0.95%
1 week+6.80%
Current month+6.80%
1 month+6.80%
3 months+28.88%
6 months+36.12%
Current year+36.22%
1 week 16.27
Extreme 16.27
17.16
1 month 14.94
Extreme 14.94
17.16
Current year 12.19
Extreme 12.19
17.53
1 year 8.62
Extreme 8.625
17.53
3 years 6.85
Extreme 6.85
17.53
5 years 6.85
Extreme 6.85
17.53
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 2023-03-31
Director of Finance/CFO 59 2026-05-07
Chief Tech/Sci/R&D Officer - 2023-12-14
Director TitleAgeSince
Director/Board Member 78 2020-11-15
Director/Board Member 78 2020-11-15
Director/Board Member 62 2020-11-15
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

2,756 0.0002%
06-29Free

Director

2,362 0.0002%
06-24Sell

Chief Financial Officer

-50,076 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%+6.80%+84.35%+72.01% 19.75B
+2.96%+3.01%+59.87%+173.31% 1,102B
+3.05%+5.23%+72.11%+67.81% 643B
-0.04%+1.20%+35.72%+87.93% 450B
+0.41%-2.07%+27.62%+22.57% 336B
-1.07%-0.76%+28.70%+47.94% 288B
-1.96%+2.40%-26.98%-40.01% 222B
+0.45%+1.65%+25.65%+68.35% 199B
+5.21%+7.93%+21.99%+83.23% 169B
+1.48%-0.04%-4.64%-32.25% 137B
Average +0.54%+2.48%+32.44%+55.09% 356.49B
Weighted average by Cap. +1.36%+1.88%+42.03%+87.33%

Financials

2026 *2027 *
Net sales 14.77B 12.93B 11.92B 11.04B 20.97B 1,402B 21.3B 143B 55.56B 692B 55.47B 54.27B 2,392B 15.04B 13.16B 12.13B 11.24B 21.34B 1,427B 21.68B 145B 56.55B 704B 56.46B 55.23B 2,435B
Net income 13M 11.37M 10.48M 9.72M 18.44M 1.23B 18.74M 126M 48.88M 609M 48.8M 47.74M 2.1B 498M 435M 401M 372M 706M 47.22B 717M 4.81B 1.87B 23.3B 1.87B 1.83B 80.55B
Net Debt 12.19B 10.66B 9.83B 9.11B 17.29B 1,157B 17.57B 118B 45.83B 571B 45.75B 44.76B 1,973B 11.03B 9.65B 8.9B 8.25B 15.65B 1,047B 15.9B 107B 41.48B 517B 41.41B 40.52B 1,786B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26-07-07 US$16.96 +0.95% 9,803,415
26-07-06 US$16.80 +0.60% 11,422,070
26-07-02 US$16.70 +3.21% 9,042,025
26-07-01 US$16.18 +1.89% 13,488,471
26-06-30 US$15.88 -2.16% 10,545,203
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.96USD
Average target price
17.81USD
Spread / Average Target
+5.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock